Research summary
All seven contributions are Global Burden of Disease (GBD) Study consortium papers covering risk-factor exposure, disease prevalence, and mortality estimates at global, regional, and national levels. A 2017 GBD 2016 comparative risk assessment quantified attributable deaths and disability-adjusted life-years (DALYs) for 84 behavioural, environmental, occupational, and metabolic risk factors with age, sex, year, and location stratification, providing long time-series trends to inform health-surveillance and policy [6]. A 2018 GBD 2016 paper estimated alcohol use and alcohol-attributable deaths and DALYs in 195 locations from 1990–2016 using 694 individual and population-level data sources [5]. A 2017 GBD 2015 analysis synthesised 2,818 data sources via spatiotemporal Gaussian-process regression to estimate daily-smoking prevalence and attributable disease burden in 195 countries [7]. A 2016 JAMA Oncology paper estimated incidence, mortality, YLDs, YLLs, and DALYs for 32 cancer groups across 195 countries from 1990–2015, using vital-registration, cancer-registry, and verbal-autopsy data and modelled mortality-to-incidence ratios [2]. A 2016 Lancet pooled analysis of 751 population-based studies (4.4 million participants) estimated worldwide diabetes trends since 1980 against the WHO target to halt rising prevalence at 2010 levels by 2025 [4]. A 2021 Lancet Neurology paper applied the GBD 2019 analytical pipeline to stroke incidence, prevalence, mortality, disability, and risk-factor population-attributable fractions [1]. A 2022 Lancet Public Health paper forecasts dementia prevalence to 2050 by country, incorporating three modifiable risk factors into prior GBD-based estimates [3]. The contributions reflect membership in large GBD writing groups producing standardised global health-metric estimates.
Recent publications
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019DOI
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015DOI
- Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019DOI
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participantsDOI
- Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016DOI
- Colorectal cancerDOI
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016DOI
- Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015DOI
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transitionDOI
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based studyDOI
The lab page does not clearly state student acceptance status. Email the professor directly to confirm.
How to apply
Email Hermann Brenner 6-12 months before your application deadline. Read several recent papers and reference specific work in your message. Use our how to email a Japanese professor guide for the proven email structure.
For applications via MEXT scholarship: see our MEXT 2027 complete guide and university-specific University Recommendation track.
External profiles
- ORCID: https://orcid.org/0000-0002-6129-1572
- OpenAlex: openalex.org
Profile compiled from public sources (Researchmap, OpenAlex, Keio University faculty directory). Last refreshed 2026-05. Report incorrect information.